The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong

INTRODUCTION: In Hong Kong (HK), a single-cohort vaccination program for 10–12-year-old girls with the 9-valent human papillomavirus (HPV) vaccine (9vHPV; types 6/11/16/18/31/33/45/52/58) has been launched. This study assessed the public health impact and cost-effectiveness of implementing routine 9...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheung, Tak Hong, Cheng, Sally Shuk Yee, Hsu, Danny C., Wong, Queenie Wing-Lei, Pavelyev, Andrew, Walia, Anuj, Saxena, Kunal, Prabhu, Vimalanand S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606050/
https://www.ncbi.nlm.nih.gov/pubmed/34801050
http://dx.doi.org/10.1186/s12962-021-00328-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606050/
https://www.ncbi.nlm.nih.gov/pubmed/34801050
http://dx.doi.org/10.1186/s12962-021-00328-x

Ejemplares similares